BRD9 Degrader-1
CAT:
804-HY-156401
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

BRD9 Degrader-1
- UNSPSC Description: BRD9 Degrader-1 (Compound 13-7) is a PROTAC BRD9 degrader[1]. BRD9 Degrader-1 has a micromolar binding affinity for BRD9 and a nanomolar affinity for the BRD9-VCB ternary complex. BRD9 Degrader-1 induces BRD9 proteasome degradation in HEK293T cells, which can be reversed by MLN4924 (HY-70062)。(Blue: VH032-cyclopropane-F (HY-125905); Black: linker (HY-W763939); Pink: HY-168695)[1].
- Target Antigen: Epigenetic Reader Domain; PROTACs
- Type: Reference compound
- Related Pathways: Epigenetics;PROTAC
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/brd9-degrader-1.html
- Solubility: 10 mM in DMSO
- Smiles: [H][C@]1([C@@H](CCOC2=CC(C3=C(C)N=CS3)=CC=C2CNC([C@H]4N(C([C@H](C(C)(C)C)NC(C5(CC5)F)=O)=O)C[C@@H](C4)O)=O)[C@]1([H])C6)CN6C7=NC(N(C(C)C)CCNC(C)=O)=NC(N8CC(C8)OC9=NC=CS9)=N7
- Molecular Weight: 1017.25
- References & Citations: [1]Liu S,et al. Rational Screening for Cooperativity in Small-Molecule Inducers of Protein-Protein Associations. J Am Chem Soc. 2023 Oct 25;145(42):23281-23291.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported